Collagen, the primary structural element in skin, makes up about 80% of its dry weight. Various factors, such as aging, ultraviolet radiation, hormones, and nutrition, can impact skin properties. VERISOL® is designed to boost skin metabolism and combat the loss of collagenous extracellular matrix from within.
By consuming the natural Bioactive Collagen Peptides® VERISOL®—specifically optimized for beauty applications—users may experience noticeably firmer, smoother skin with reduced wrinkles. VERISOL's positive effects also include improved skin surface structure, decreased cellulite, and faster nail growth with less chipping. To cater to diverse consumer preferences, VERISOL® is available from various raw material sources, including porcine, bovine, or marine origins.
Mode of Action
VERISOL®'s unique peptides are identified by fibroblast cells in the skin's dermal layer as collagen fragments similar to those produced by catabolic processes. As a result, these cells are prompted to enhance their collagen metabolism to counteract the perceived collagen degradation in the dermis. This leads to a significantly increased production of dermal collagen and the overall extracellular matrix, compensating for the losses caused by aging and environmental factors.
Enhanced Skin Health with VERISOL®
VERISOL® is composed of specialized collagen peptides that support healthy skin. When consumed orally, VERISOL® directly impacts skin collagen metabolism, boosting skin hydration and delaying wrinkle formation. Several scientific studies have explored the potential of VERISOL®.
Increased Skin Elasticity¹
A study involving 69 women aged between 35 and 55 revealed that VERISOL® significantly improves skin elasticity by up to 15% compared to a placebo treatment. This effect was observed after just 4 weeks and persisted after 8 weeks of oral VERISOL® consumption. Even 4 weeks after the last intake, VERISOL® still demonstrated higher skin elasticity levels than the placebo group.
Another study with over 100 women aged between 45 and 65 found that oral VERISOL® administration significantly reduced wrinkles after 4 weeks and increased skin procollagen concentration.
Improved Skin Surface & Cellulite Reduction
Approximately 85% of adult women worldwide are affected by cellulite. While not a disease, cellulite is a cosmetic concern. It primarily results from dermal matrix disturbances, excess subcutaneous fat, and increased interstitial fluid.
VERISOL® supplementation positively impacts the skin's dermal extracellular matrix and can help reduce cellulite. Unlike other cellulite supplements that target excess fat or microcirculation/drainage, VERISOL® directly stimulates extracellular matrix formation in the skin.
Significant Cellulite Score Decrease³
A double-blind, randomized, placebo-controlled study involving 105 women aged between 25 and 50 demonstrated that daily oral intake of VERISOL® significantly decreased cellulite scores after 3 and 6 months of supplementation. VERISOL® improved skin extracellular matrix and restored the normal structure of the dermis and subcutaneous tissue. It also reduced skin waviness, with initial results visible after 3 months and more pronounced after 6 months. In women with a BMI < 25, VERISOL® significantly reduced the appearance of cellulite.
Fingernail Growth & Health Promotion⁴
Many women consider well-groomed fingernails an essential aspect of an attractive appearance. However, cracked or chipped nails, nail peeling, and roughness are common issues. VERISOL®'s Bioactive Collagen Peptides (BCP®) can help improve nail growth and health.
A recent study showed a 42% decrease in cracked and/or chipped nails after 6 months of VERISOL® treatment. Nail growth speed increased compared to the control group, with a statistically significant improvement in nail growth observed after 3 months. Nail peeling and edge irregularity also improved noticeably. 80% of participants were completely satisfied with VERISOL® treatment, with 75% perceiving their nails as longer and 71% reporting faster nail growth.
¹ Proksch E., et al. Skin Pharmacol Physiology, August 2013
² Proksch E., et al. Skin Pharmacol Physiology, December 2013
³ Schunck M., et al. J Med Food, 2015
⁴ Hexsel D., et al. J Cosmet Dermatol, 2017